Full history for every metric is available with a Kvantra account
Lutronic Corporation (085370.KQ)
Key financial summary
Financials in KRW| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | KRW bn | 86 | 92 | 115 | 116 | 174 | 264 | 273 |
| Operating profit | KRW bn | 59 | 37 | |||||
| Net profit | KRW bn | -7 | -7 | -21 | -16 | 28 | 45 | 29 |
| EPS reported | KRW | 1,751 | 1,088 | |||||
| Operating cashflow per share | KRW | 935.9 | 935.9 | |||||
| Capex per share | KRW | 82.66 | 82.66 | |||||
| FCF per share | KRW | 853.2 | 853.2 | |||||
| Free cash flow | KRW bn | 22 | 2 | |||||
| Net debt | KRW bn | -86 | -71 | |||||
| Book value equity | KRW bn | 161 | 159 | |||||
| Book value per share | KRW | 6,231 | 6,199 | |||||
| Number of shares | m | 25.79 | 25.62 | |||||
| DPS (TTM paid) | KRW | 322.0 | 322.0 |
Financial summary
Financials in KRW| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 11.28 | - | |||||
| P/B LTM | x | 3.06 | 5.78 | |||||
| P/S LTM | x | 1.86 | 3.36 | |||||
| P/FCF LTM | x | 22.33 | 600.99 | |||||
| EV/EBITDA LTM | x | 6.71 | 18.32 | |||||
| EV/Sales LTM | x | 1.69 | 3.10 | |||||
| Earnings Yield LTM | % | 8.87% | 4.78% | |||||
| FCF Yield | % | 4.48% | 0.17% | |||||
| Quality | ||||||||
| ROE | % | 28.11% | 32.04% | |||||
| ROIC | % | 28.28% | 28.28% | |||||
| Operating margin | % | 22.27% | 22.27% | |||||
| Gross margin | % | 64.11% | 64.11% | |||||
| FCF/Sales | % | 8.33% | 8.33% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | +62.98% | -22.58% | |||||
| Sales Growth YoY | % | +52.12% | +26.82% | |||||
| Net Income Growth YoY | % | +63.35% | -26.23% | |||||
| FCF Growth | % | -35.13% | -95.25% | |||||
| Operating Profit Growth | % | +58.10% | -28.83% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 1.01% | 0.88% | |||||
| Dividend Growth | % | - | - | |||||
| Payout Ratio | % | 11.01% | 29.03% | |||||
| FCF/Debt | x | - | - | |||||
| Net Debt/EBITDA | x | -0.67 | -0.67 | |||||
| EBIT/Net interest | x | 0.00 | 0.00 | |||||
| Net debt/market cap | % | -17.42% | -7.76% | |||||
| Net debt/Equity | x | -0.53 | -0.45 | |||||
| Gross debt/equity | x | 0.00 | 0.00 | |||||
Company overview
Lutronic Corporation, headquartered in Goyang, South Korea, is a global innovator in the development and distribution of advanced laser and related technologies for both aesthetic and medical applications. The company's extensive portfolio encompasses a variety of sophisticated solutions, including: HOLLYWOOD SPECTRA, a distinguished laser platform with proprietary capabilities to diminish unwanted pigmentation and enhance skin luminosity. Accufit, designed to deliver direct muscle activation treatments for refined aesthetic outcomes. LUTRONIC GENIUS, which ensures exceptional precision with every energy pulse. CLARITY II, a cutting-edge dual-wavelength laser platform featuring intelligent breakthrough functionalities. LaseMD Ultra, providing tailored patient results with virtually no recovery period. SPECTRA XT, recognized as a state-of-the-art medical device. CLARITY, another dual-wavelength platform offering broad treatment versatility and increased operational speed. LASEMD, an adaptable platform capable of implementing a cosmeceutical delivery system for comprehensive skincare. SPECTRA, known for its effective treatments that require minimal patient downtime. PICOPLUS, specifically engineered for the treatment of melasma. ACTION II, which utilizes specialized multiple stacking fractional technology, allowing clinicians to control ablation depth and coagulation for a nearly painless procedure. Lutronic’s offerings further extend to include: eCO2, a premier fractional ablative CO2 laser. INFINI, a unique technology that delivers fractional radiofrequency energy through insulated microneedles. HEALITE II, which therapeutically harnesses incident light to modulate cellular function. SOLARI, an advanced IPL system. In addition to individual devices, the company provides integrated solutions such as: TotalSkin Solution, a comprehensive approach designed to address all layers of the skin and satisfy diverse patient expectations. KeraFactor Peptide Complex, a specialized treatment targeting hair and scalp health. The Hollywood Laser Peel, a swift and comfortable procedure facilitated by the Lutronic Spectra laser platform. Founded in 1997, the company was initially known as Max Engineering Ltd. before rebranding to Lutronic Corporation in 2006.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Lutronic Corporation (085370.KQ)
Lutronic Corporation, headquartered in Goyang, South Korea, is a global innovator in the development and distribution of advanced laser and related technologies for both aesthetic and medical applications. The company's extensive portfolio encompasses a variety of sophisticated solutions, including: HOLLYWOOD SPECTRA, a distinguished laser platform with proprietary capabilities to diminish unwanted pigmentation and enhance skin luminosity. Accufit, designed to deliver direct muscle activation treatments for refined aesthetic outcomes. LUTRONIC GENIUS, which ensures exceptional precision with every energy pulse. CLARITY II, a cutting-edge dual-wavelength laser platform featuring intelligent breakthrough functionalities. LaseMD Ultra, providing tailored patient results with virtually no recovery period. SPECTRA XT, recognized as a state-of-the-art medical device. CLARITY, another dual-wavelength platform offering broad treatment versatility and increased operational speed. LASEMD, an adaptable platform capable of implementing a cosmeceutical delivery system for comprehensive skincare. SPECTRA, known for its effective treatments that require minimal patient downtime. PICOPLUS, specifically engineered for the treatment of melasma. ACTION II, which utilizes specialized multiple stacking fractional technology, allowing clinicians to control ablation depth and coagulation for a nearly painless procedure. Lutronic’s offerings further extend to include: eCO2, a premier fractional ablative CO2 laser. INFINI, a unique technology that delivers fractional radiofrequency energy through insulated microneedles. HEALITE II, which therapeutically harnesses incident light to modulate cellular function. SOLARI, an advanced IPL system. In addition to individual devices, the company provides integrated solutions such as: TotalSkin Solution, a comprehensive approach designed to address all layers of the skin and satisfy diverse patient expectations. KeraFactor Peptide Complex, a specialized treatment targeting hair and scalp health. The Hollywood Laser Peel, a swift and comfortable procedure facilitated by the Lutronic Spectra laser platform. Founded in 1997, the company was initially known as Max Engineering Ltd. before rebranding to Lutronic Corporation in 2006.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free